Clinical Trial Update: FINRISK 2002 Re-examination

View source ↗

Summary

This clinical trial update notes that the FINRISK 2002 re-examination study, sponsored by the University of Turku, has completed and focused on cardiometabolic …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiometabolic Syndrome
• Cardiovascular Diseases

Snippet

Sponsor: University of Turku | Conditions: Cardiometabolic Syndrome, Cardiovascular Diseases | Status: COMPLETED